The main strategy of cancer treatment has focused on attacking the tumor cells. Some
cancers initially responsive to chemotherapy become treatment-resistant. Another strategy is …

Cell-based drug delivery systems have shown tremendous advantages in cancer treatment
due to their distinctive properties. For instance, delivery of therapeutics using tumor-tropic …

Current clinical therapeutic efficacy for the treatment of osteo‐and rheumatoid‐arthritis is
obviously limited. Although mesenchymal stem cells (MSCs) are considered as a source of …

Mesenchymal stem cells (MSCs), as self-renewing multipotent stromal cells, have been
considered promising agents for cancer treatment. A large number of studies have …

Cancer vaccines hold considerable promise for the immunotherapy of solid tumors.
Nanomedicine offers several strategies for enhancing vaccine effectiveness. In particular …

This review aims to summarize the methods that have been used till today, highlight
methods that are currently being developed, and predict the future roadmap for anticancer …

Mesenchymal stem cells (MSCs) accumulate specifically in both primary tumors and
metastases following systemic administration. However, the poor payload capacity of MSCs …

Mesenchymal stem cells (MSCs) intrinsically possess unique features that not only help in
their migration towards the tumor-rich environment but they also secrete versatile types of …

Targeting actionable mutations in oncogene‐driven cancers and the evolution of immuno‐
oncology are the two prominent revolutions that have influenced cancer treatment …

Intracellular cargo delivery, the introduction of small molecules, proteins, and nucleic acids
into a specific targeted site in a biological system, is an important strategy for deciphering …